[
    {
        "id": "osp-12342",
        "type": "article-journal",
        "title": "Fractured dexamethasone implant (OZURDEX®) following intravitreal injection",
        "author": [
            {
                "family": "Aljohani",
                "given": "Saud M"
            },
            {
                "family": "Al-Shehri",
                "given": "Abdulaziz M"
            },
            {
                "family": "Al-Rubaie",
                "given": "Khalid R"
            }
        ],
        "URL": "https://omanscience.com/en/articles/fractured-dexamethasone-implant-ozurdex-following-intravitreal-injection",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2021
                ]
            ]
        },
        "container-title": "Oman Journal of Ophthalmology",
        "volume": "14",
        "issue": "3",
        "page": "201-202",
        "DOI": "10.4103/ojo.ojo_31_21",
        "publisher": "Medknow Publications",
        "ISSN": "0974-620X",
        "abstract": "Dexamethasone implant (Ozurdex™) is a relatively safe medication with few adverse events can happen. We demonstrate clinical course and images of a rare case of fractured intravitreal Ozurdex™ implant that observed immediately following injection and its final outcome."
    }
]